# A Study to Evaluate the Efficacy and Safety of CC-93538 in Adult and Adolescent Japanese Participants With Eosinophilic Gastroenteritis

> **NCT05214768** · PHASE3 · COMPLETED · sponsor: **Celgene** · enrollment: 48 (actual)

## Conditions studied

- Eosinophilic Gastroenteritis

## Interventions

- **DRUG:** CC-93538
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05214768
- **Lead sponsor:** Celgene
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-03-04
- **Primary completion:** 2024-07-02
- **Final completion:** 2025-08-22
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2025-10-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05214768

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05214768, "A Study to Evaluate the Efficacy and Safety of CC-93538 in Adult and Adolescent Japanese Participants With Eosinophilic Gastroenteritis". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT05214768. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*